nach oben

Journal of Assisted Reproduction and Genetics

Erschienen in:

09.08.2019 | Assisted Reproduction Technologies

Ovarian stimulation and egg retrieval in the acutely ill patient: special considerations

verfasst von: Kaitlyn Wald, Joseph Letourneau, Rachel Eshima-McKay, John Monks, Evelyn Mok-Lin, Marcelle Cedars, Mitchell Rosen

Erschienen in: Journal of Assisted Reproduction and Genetics | Ausgabe 10/2019

Einloggen, um Zugang zu erhalten

Excerpt

Over the past decades, assisted reproductive care has become increasingly safe and more widely applied. Egg retrieval has become an outpatient procedure, with ultrasound guidance, and stimulations have increasingly become less aggressive and safer with more individualization and safer trigger options. With this improvement in care, these treatments are considered low risk and applied more widely, including fertility preservation for elective reasons (so-called social egg freezing). However, it is incumbent upon providers to realize the application of even “simple” treatments, in a high-risk population, may have serious consequences. …

Centers for Disease Control. A national action plan for cancer survivorship: advancing public health strategies. 2004 12/20/2018]; Available from: https://www.cdc.gov/cancer/survivors/pdf/plan.pdf.

Surveillance, epidemiology, and end results program. Cancer statistics and review 1975–2015. [cited 2018; Available from: http://www.seer.cancer.gov.

Letourneau JM, Ebbel EE, Katz PP, Katz A, Ai WZ, Chien AJ, et al. Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer. Cancer. 2012;118(6):1710–7.PubMedCrossRef

Ethics Committee of the American Society for Reproductive Medicine. Electronic address, A.a.o., Fertility preservation and reproduction in patients facing gonadotoxic therapies: an Ethics Committee opinion. Fertil Steril, 2018. 110(3): p. 380–386.

Anazodo A, Ataman-Millhouse L, Jayasinghe Y, Woodruff TK. Oncofertility-an emerging discipline rather than a special consideration. Pediatr Blood Cancer. 2018;65(11):e27297.PubMedPubMedCentralCrossRef

Ataman LM, Ma Y, Duncan FE, Uzzi B, Woodruff TK. Quantifying the growth of oncofertility. Biol Reprod. 2018;99(2):263–5.PubMedPubMedCentralCrossRef

Letourneau JM, Sinha N, Wald K, Harris E, Quinn M, Imbar T, et al. Random start ovarian stimulation for fertility preservation appears unlikely to delay initiation of neoadjuvant chemotherapy for breast cancer. Hum Reprod. 2017;32(10):2123–9.PubMedCrossRef

Pecker LH, Maher JY, Law JY, Beach MC, Lanzkron S, Christianson MS. Risks associated with fertility preservation for women with sickle cell anemia. Fertil Steril. 2018;110(4):720–31.PubMedCrossRef

Ferschl MB, Tung A, Sweitzer BJ, Huo D, Glick DB. Preoperative clinic visits reduce operating room cancellations and delays. Anesthesiology. 2005;103(4):855–9.PubMedCrossRef

10.

Reilly DF, McNeely MJ, Doerner D, Greenberg DL, Staiger TO, Geist MJ, et al. Self-reported exercise tolerance and the risk of serious perioperative complications. Arch Intern Med. 1999;159(18):2185–92.PubMedCrossRef

11.

Subramani Y, Wong J, Nagappa M, Chung F. The benefits of perioperative screening for sleep apnea in surgical patients. Sleep Med Clin. 2017;12(1):123–35.PubMedCrossRef

12.

Cartagena R. Preoperative evaluation of patients with obesity and obstructive sleep apnea. Anesthesiol Clin North Am. 2005;23(3):463–78 vi.PubMedCrossRef

13.

Subramani Y, Nagappa M, Wong J, Mubashir T, Chung F. Preoperative evaluation: estimation of pulmonary risk including obstructive sleep apnea impact. Anesthesiol Clin. 2018;36(4):523–38.PubMedCrossRef

14.

Devereaux PJ, Sessler DI. Cardiac complications in patients undergoing major noncardiac surgery. N Engl J Med. 2015;373(23):2258–69.PubMedCrossRef

15.

Bechard P, et al. Perioperative cardiorespiratory complications in adults with mediastinal mass: incidence and risk factors. Anesthesiology. 2004;100(4):826–34; discussion 5A.PubMedCrossRef

16.

Grocott HP, Gulati H, Srinathan S, Mackensen GB. Anesthesia and the patient with pericardial disease. Can J Anaesth. 2011;58(10):952–66.PubMedCrossRef

17.

Goh MH, Liu XY, Goh YS. Anterior mediastinal masses: an anaesthetic challenge. Anaesthesia. 1999;54(7):670–4.PubMedCrossRef

18.

Graetz T, N.D. Perioperative strategies to reduce bleeding and minimize transfusions. UpToDate. 2018; Available from: http://www.uptodate.com.

19.

McCullough J. Overview of platelet transfusion. Semin Hematol. 2010;47(3):235–42.PubMedCrossRef

20.

Carson JL, Guyatt G, Heddle NM, Grossman BJ, Cohn CS, Fung MK, et al. Clinical practice guidelines from the AABB red blood cell transfusion thresholds and storage. Jama-J Am Med Assoc. 2016;316(19):2025–35.CrossRef

21.

Ye R, et al. Timing embryo preservation for a patient with high-risk newly diagnosed acute myeloid leukemia. Case Rep Hematol. 2018;2018:9807047.PubMedPubMedCentral

22.

Meirow D, Epstein M, Lewis H, Nugent D, Gosden RG. Administration of cyclophosphamide at different stages of follicular maturation in mice: effects on reproductive performance and fetal malformations. Hum Reprod. 2001;16(4):632–7.PubMedCrossRef

23.

Brunicardi FC, et al. Schwartz’s principles of surgery. Tenth ed. New York: McGraw-Hill Education; 2014.

24.

Howard SC, Jones DP, Pui CH. The tumor lysis syndrome. N Engl J Med. 2011;364(19):1844–54.PubMedPubMedCentralCrossRef

25.

Howard SC, Trifilio S, Gregory TK, Baxter N, McBride A. Tumor lysis syndrome in the era of novel and targeted agents in patients with hematologic malignancies: a systematic review. Ann Hematol. 2016;95(4):563–73.PubMedCrossRef

26.

Vormittag R, Simanek R, Ay C, Dunkler D, Quehenberger P, Marosi C, et al. High factor VIII levels independently predict venous thromboembolism in cancer patients: the cancer and thrombosis study. Arterioscler Thromb Vasc Biol. 2009;29(12):2176–81.PubMedCrossRef

27.

Walker AJ, Card TR, West J, Crooks C, Grainge MJ. Incidence of venous thromboembolism in patients with cancer - a cohort study using linked United Kingdom databases. Eur J Cancer. 2013;49(6):1404–13.PubMedCrossRef

28.

Mahajan A, et al. The epidemiology of cancer-associated venous thromboembolism: an update. Semin Thromb Hemost. 2019.

29.

Chan WS. The ‘ART’ of thrombosis: a review of arterial and venous thrombosis in assisted reproductive technology. Curr Opin Obstet Gynecol. 2009;21(3):207–18.PubMedCrossRef

30.

Rova K, Passmark H, Lindqvist PG. Venous thromboembolism in relation to in vitro fertilization: an approach to determining the incidence and increase in risk in successful cycles. Fertil Steril. 2012;97(1):95–100.PubMedCrossRef

31.

Bates SM, Middeldorp S, Rodger M, James AH, Greer I. Guidance for the treatment and prevention of obstetric-associated venous thromboembolism. J Thromb Thrombolysis. 2016;41(1):92–128.PubMedPubMedCentralCrossRef

32.

Gurunath S, Vinekar S, Biliangady R. Assisted reproductive techniques in a patient with history of venous thromboembolism: a case report and review of literature. J Hum Reprod Sci. 2018;11(2):193–7.PubMedPubMedCentralCrossRef

33.

Somigliana E, Peccatori FA, Filippi F, Martinelli F, Raspagliesi F, Martinelli I. Risk of thrombosis in women with malignancies undergoing ovarian stimulation for fertility preservation. Hum Reprod Update. 2014;20(6):944–51.PubMedCrossRef

34.

Practice Committee of the American Society for Reproductive Medicine. Electronic address, A.a.o. and M. Practice Committee of the American Society for reproductive, prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline. Fertil Steril, 2016. 106(7): p. 1634–1647.

35.

Goldsman MP, Pedram A, Dominguez CE, Ciuffardi I, Levin E, Asch RH. Increased capillary permeability induced by human follicular fluid: a hypothesis for an ovarian origin of the hyperstimulation syndrome. Fertil Steril. 1995;63(2):268–72.PubMedCrossRef

36.

Namavar Jahromi BM, et al. Ovarian hyperstimulation syndrome: a narrative review of its pathophysiology, risk factors, prevention, classification, and management. Iran J Med Sci. 2018;43(3):248–60.

37.

Claesson-Welsh L. Vascular permeability--the essentials. Ups J Med Sci. 2015;120(3):135–43.PubMedPubMedCentralCrossRef

38.

Toftager M, Bogstad J, Bryndorf T, Løssl K, Roskær J, Holland T, et al. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles. Hum Reprod. 2016;31(6):1253–64.PubMedCrossRef

39.

Youssef MA, et al. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles. Cochrane Database Syst Rev. (2011, 1):CD008046.

40.

Anaya Y, Mata DA, Letourneau J, Cakmak H, Cedars MI, Rosen MP. A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols (vol 35, pg 297, 2017). J Assist Reprod Genet. 2018;35(2):309–9.

Titel: Ovarian stimulation and egg retrieval in the acutely ill patient: special considerations
verfasst von: Kaitlyn Wald
Joseph Letourneau
Rachel Eshima-McKay
John Monks
Evelyn Mok-Lin
Marcelle Cedars
Mitchell Rosen
Publikationsdatum: 09.08.2019
Verlag: Springer US
Erschienen in: Journal of Assisted Reproduction and Genetics / Ausgabe 10/2019
Print ISSN: 1058-0468
Elektronische ISSN: 1573-7330
DOI: https://doi.org/10.1007/s10815-019-01556-0

Neu im Fachgebiet Gynäkologie und Geburtshilfe

23.04.2024 | Medikamente in Schwangerschaft und Stillzeit | Nachrichten

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Ovarian stimulation and egg retrieval in the acutely ill patient: special considerations

Excerpt

Neu im Fachgebiet Gynäkologie und Geburtshilfe

ICI-Therapie in der Schwangerschaft wird gut toleriert

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Gynäkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2019

FoxO transcription factors 1 regulate mouse preimplantation embryo development

Dehydroepiandrosterone supplementation attenuates ovarian ageing in a galactose-induced primary ovarian insufficiency rat model

Double intrauterine insemination (IUI) of no benefit over single IUI among lesbian and single women seeking to conceive

Anonymous sperm donors’ attitude towards donation and the release of identifying information

Correction to: Development of an efficient perfusion-based protocol for whole-organ decellularization of the ovine uterus as a human-sized model and in vivo application of the bioscaffolds

Hospitalization before and after delivery in fertile, subfertile, and ART-treated women

Neu im Fachgebiet Gynäkologie und Geburtshilfe

ICI-Therapie in der Schwangerschaft wird gut toleriert

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Gynäkologie